Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Latest research on Global Breast Cancer Monoclonal Antibodies Market report covers forecast and analysis on a worldwide, regional and country level. T
Defendants. This notice is for all persons or entities who purchased or otherwise acquired Array Biopharma, Inc. Common Stock between June 30, 2016 and March 17, 2017, inclusive (the "Class"). YOU ARE HEREBY NOTIFIED that pursuant to an Order of the United States District Court for the District of Colorado, a hearing will be held on October 29, 2021, at 2:30 p.m., before the Honorable Kristen L. Mix, United States District Judge, at the Courthouse for the United States District Court, District of Colorado, Courtroom A401, Alfred A. Arraj United States Courthouse, 901 19 th St, Denver, CO ...
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results IND cleared for Phase 2 study of CGT9486, a selective mutant KIT inhibitor, in Advanced Systemic Mastocytosis patients John Robinson, PhD appointed as Chief Scientific Officer to lead newly created Cogent Research team Evan Kearns, JD joined Cogent as Chief Legal Officer Ended Q1 2021 with $230.7 million in cash, sufficient to fund operations into 2024 News provided by Share this article Share this article CAMBRIDGE, Mass. and BOULDER, Colo., May 12, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (...
The ongoing pandemic has created a wealth of interest from venture capital investors and the broader public in what biotech companies are able to achieve if it’s flush with resources. That was the sentiment of a group of Boulder area biotechnology industry leaders, who met virtually at BizWest’s CEO Roundtable on the biotechnology industry Tuesday morning. Steady stream of investor dollars Biotech was one of the few industries that was relatively unaffected from a financial standpoint during the pandemic, and multiple companies marked significant financial milestones just in the past few ...
DENVER — The Colorado Bioscience Association said the state’s biotech industry set a record for new venture funding in the first quarter of 2021, with a lion’s share of those dollars coming from Boulder-area companies. The trade association said Tuesday that biotech companies in the state raised $704 million in the last quarter. That figure is more than half of the $1.2 billion in venture funding issued in the entirety of 2020 and well on its way toward eclipsing the $850 million or so issued in 2019. Those annual figures do not include Pfizer Inc. (NYSE: PFE) acquiring Array Biopharma ...